£7.5M
The Scottish National Investment Bank led the Series A round to accelerate clinical validation and regulatory submission of the company's respiratory monitoring platform.
P
PneumoWave
PneumoWave develops a wearable biosensor platform for remote respiratory monitoring.
£7.5MTotal raised
PneumoWave develops wearable biosensor technology designed to remotely diagnose and monitor potentially fatal respiratory changes. The digital health business focuses on preventing deaths and reducing hospital admissions.
Categories
Founders
BH
Bruce Henderson
CEO